CANTICANTI home
Back to diseases

Disease hub

Prostate cancer

Open Targets catalogue label: prostate cancer

Prostatic malignancy bucket — navigation-only aggregation of structured rows and trial mirrors.

Data: Live structured evidence (Supabase)

Source catalogue
11035
Imported rows
—
Explorer-eligible
—
Targets w/ drugs
—
Open guided lookup (general disease context)
Also indexed as

prostatic adenocarcinoma · PCa · prostate cancer · MONDO_0008315 · malignant prostate neoplasm · malignant neoplasm of prostate · malignant neoplasm of prostate gland · malignant neoplasm of the prostate · malignant prostate tumor · NGP - new growth of prostate · malignant prostate gland neoplasm · prostate gland cancer · prostatic cancer · malignant prostate tumour · cancer of prostate gland · malignant tumour of the prostate · malignant tumor of the prostate · malignant tumor of prostate · malignant tumour of prostate · prostate cancer, familial · hereditary prostate cancer · prostate neoplasm · tumor of the prostate · tumour of the prostate · prostatic neoplasm · UMLS:C0376358 · ICD9:185 · MESH:D011471 · DOID:10283 · NCIT:C7378 · SCTID:399068003 · MEDGEN:138169

Limitations & build flags

  • Read-only structured navigator
  • No clinical outcome benefit inferred
  • Trial presence does not imply success
  • Drug identity may require normalization
  • Terminated/withdrawn trials must remain visible
Disease–target coverage
Coverage metrics for this hub when live evidence-graph and catalogue snapshots are available.
Source catalogue associations
11,035

Open Targets associated-target catalogue count for this disease node — not clinically ranked, validated, or treatment-linked targets.

Measured from Open Targets on 2026-05-15

Imported evidence rows
—

Source evidence rows, not unique targets.

Explorer-eligible targets
—

Targets in the GBM evidence-graph view with default dashboard eligibility.

Targets with drug relationships
—

Distinct active GBM explorer-eligible targets with drug–target mechanism-of-action relationships (disease-scoped; not a global catalogue count).

Disease-linked drugs
—

Unique active drugs linked to this disease in the evidence graph.

Disease-drug evidence edges
—

Active disease–drug evidence edges (methodology detail).

Catalogue and row counts are research inventory signals. They do not mean every association is clinically relevant, validated, druggable, or treatment-linked.